Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Arif Mahmood, Abdus Samad, Shazia Bano, Muhammad Umair, Amar Ajmal, Iqra Ilyas, Abid Ali Shah, Ping Li & Junjian Hu. (2023) Structural and dynamics insights into the GBA variants associated with Parkinson’s disease. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Christiana Mantzourani, Sofia Vasilakaki, Velisaria-Eleni Gerogianni & George Kokotos. (2022) The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opinion on Drug Discovery 17:3, pages 231-246.
Read now
Read now
Jin-Ryul Hu, Chul-Jong Jung, Seong-Min Ku, Dae-Hwa Jung, Khawaja Muhammad Imran Bashir, Sae-Kwang Ku & Jae-Suk Choi. (2021) Anti-inflammatory, expectorant, and antitussive properties of Kyeongok-go in ICR mice. Pharmaceutical Biology 59:1, pages 319-332.
Read now
Read now
Ahmad Bani-Jaber & Samaa Abdullah. (2020) Development and characterization of novel ambroxol sustained-release oral suspensions based on drug-polymeric complexation and polymeric raft formation. Pharmaceutical Development and Technology 25:6, pages 666-675.
Read now
Read now
Dorotheea Cazan, Ludger Klimek, Annette Sperl, Manuel Plomer & Stephan Kölsch. (2018) Safety of ambroxol in the treatment of airway diseases in adult patients. Expert Opinion on Drug Safety 17:12, pages 1211-1224.
Read now
Read now
Yongchun Shen, Shaoguang Huang, Jian Kang, Jiangtao Lin, Kefang Lai, Yongchang Sun, Wei Xiao, Lan Yang, Wanzhen Yao, Shaoxi Cai, Kewu Huang & Fuqiang Wen. (2018) Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). International Journal of Chronic Obstructive Pulmonary Disease 13, pages 399-407.
Read now
Read now
Kai-Uwe Kern & Myriam Schwickert. (2017) Ambroxol for the treatment of fibromyalgia: science or fiction?. Journal of Pain Research 10, pages 1905-1929.
Read now
Read now
Suruchi Singh & Raja Roy. (2016) The application of absolute quantitative 1H NMR spectroscopy in drug discovery and development. Expert Opinion on Drug Discovery 11:7, pages 695-706.
Read now
Read now
Shahida Hussain, Georgia Varelogianni, Eva Särndahl & Godfried M. Roomans. (2015) N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro. Experimental Lung Research 41:5, pages 251-260.
Read now
Read now
Sagar Pawar, Umesh Mahantshetty, Kedar Deodhar & Tanuja Teni. (2014) A simple cost-effective modification improves the quality of immunocytochemical staining in cervical scrape samples characterized by presence of excess mucus. Journal of Histotechnology 37:1, pages 3-8.
Read now
Read now
A. Abd-Elbary, M. Haider & S. Sayed. (2012) In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression. Pharmaceutical Development and Technology 17:5, pages 562-573.
Read now
Read now
Davide Paleari, Giovanni A Rossi, Gabriele Nicolini & Dario Olivieri. (2011) Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood. Expert Opinion on Drug Discovery 6:11, pages 1203-1214.
Read now
Read now
Articles from other publishers (101)
Alexis Hocquigny, Hélène Hugerot, Rosy Ghanem, Tanguy Haute, Véronique Laurent, Virginie Cogulet & Tristan Montier. (2023) Mucoactive drugs and multiple applications in pulmonary disease therapy. European Journal of Pharmaceutics and Biopharmaceutics.
Crossref
Crossref
Fabiana Colucci, Micol Avenali, Rosita De Micco, Marco Fusar Poli, Silvia Cerri, Mario Stanziano, Ana Bacila, Giada Cuconato, Valentina Franco, Diego Franciotta, Cristina Ghezzi, Matteo Gastaldi, Antonio Emanuele Elia, Luigi Romito, Grazia Devigili, Valentina Leta, Barbara Garavaglia, Nico Golfrè Andreasi, Federico Cazzaniga, Chiara Reale, Caterina Galandra, Giancarlo Germani, Pierfrancesco Mitrotti, Gerardo Ongari, Ilaria Palmieri, Marta Picascia, Anna Pichiecchio, Mattia Verri, Fabrizio Esposito, Mario Cirillo, Federica Di Nardo, Simone Aloisio, Mattia Siciliano, Sara Prioni, Paolo Amami, Sylvie Piacentini, Maria Grazia Bruzzone, Marina Grisoli, Fabio Moda, Roberto Eleopra, Alessandro Tessitore, Enza Maria Valente & Roberto Cilia. (2023)
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in
GBA
-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol
. BMJ Neurology Open 5:2, pages e000535.
Crossref
Crossref
Marc A. Russo, Ralf Baron, Anthony H. Dickenson, Kai-Uwe Kern & Danielle M. Santarelli. (2023) REPRINTED WITH PERMISSION OF IASP – PAIN 164 (2023) 3–13: Ambroxol for neuropathic pain: hiding in plain sight?. BÓL 24:3, pages 21-34.
Crossref
Crossref
Tereza Uhlíková, Ivana Šlechtová, Jan Koucký, Patrik Kania, Jan Rohlíček & Štěpán Urban. (2023) Low Energy Vibrations and Crystalline Structure of Ambroxol Hydrochloride by THz Spectroscopy and DFT Calculations. ChemistrySelect 8:33.
Crossref
Crossref
Binay Kumar Shah, Bivek Singh, Yukun Wang, Shuanshuan Xie & Changhui Wang. (2023) Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment. Mediators of Inflammation 2023, pages 1-15.
Crossref
Crossref
Dongli Qi, Bei Jia, Hui Peng, Jiachen He, Jiaxin Pi, Pan Guo, Ying Zhang, Xiuping Deng, Jiawei Li & Zhidong Liu. (2023) Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. European Journal of Pharmaceutics and Biopharmaceutics 188, pages 243-253.
Crossref
Crossref
Jurga Bernatoniene, Arunas Sciupokas, Dalia Marija Kopustinskiene & Kestutis Petrikonis. (2023) Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain. Pharmaceutics 15:7, pages 1799.
Crossref
Crossref
Zeguang Zheng, Kai Yang, Ni Liu, Xiuhua Fu, Huijie He, Hong Chen, Peijun Xu, Jing Wang, Maofeng Liu, Yuling Tang, Fengzi Zhao, Shufeng Xu, Xiaowei Yu, Jichang Han, Bo Yuan, Bin Jia, Guifen Pang, Yantong Shi, Min Kuang, Haiyan Shao, Hao Xiong, Jia He, Yuanyuan Pan & Rongchang Chen. (2023) Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty. Frontiers in Medicine 10.
Crossref
Crossref
Kristin Patzwaldt, Georgy Berezhnoy, Tudor Ionescu, Linda Schramm, Yi Wang, Miriam Owczorz, Eduardo Calderón, Sven Poli, Lina M Serna Higuita, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Kristina Herfert, Bernd Pichler, Christoph Trautwein & Salvador Castaneda-Vega. (2023) Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke. Brain Communications 5:2.
Crossref
Crossref
Mutsuo Yamaya, Akiko Kikuchi, Mitsuru Sugawara & Hidekazu Nishimura. (2023) Anti-inflammatory effects of medications used for viral infection-induced respiratory diseases. Respiratory Investigation 61:2, pages 270-283.
Crossref
Crossref
Jiaming Bian, Hong Liang & Mei Zhang. (2022)
Comparison of Clinical Effectiveness Between Ambroxol and
N
‐Acetylcysteine in Surgical Patients: A Retrospective Cohort Study
. The Journal of Clinical Pharmacology 63:2, pages 172-179.
Crossref
Crossref
Nora A. Abdallah, Mona E. Fathy, Manar M. Tolba, Amina M. El-Brashy & Fawzia A. Ibrahim. (2023) A quality-by-design eco-friendly UV-HPLC method for the determination of four drugs used to treat symptoms of common cold and COVID-19. Scientific Reports 13:1.
Crossref
Crossref
Marc A. Russo, Ralf Baron, Anthony H. Dickenson, Kai-Uwe Kern & Danielle M. Santarelli. (2023) Ambroxol for neuropathic pain: hiding in plain sight?. Pain 164:1, pages 3-13.
Crossref
Crossref
Pritam D. Sonawane, Suraj R. Chaudhari, Saurabh B. Ganorkar, Amod S. Patil & Atul A. Shirkhedkar. (2022) A brief review on critical analytical aspects for quantification of ambroxol in biological samples. Analytical Biochemistry 657, pages 114888.
Crossref
Crossref
Yun Lu, Qing-qing Yang, Lin Zhuo, Kun Yang, Hao Kou, Su-yu Gao, Wen Hu, Qiao-li Jiang, Wen-jing Li, Dong-fang Wu, Feng Sun, Hong Cheng & Siyan Zhan. (2022) Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study. Frontiers in Microbiology 13.
Crossref
Crossref
Hao-Ran Zhang, Li Liu, Long-Yuan Zheng, Yu-Qing Song, Xiao-Min Chen, Gui-Mei Tang & Yong-Tao Wang. (2022) The luminescent behaviors based on Ambroxol: Syntheses, crystal structure and Hirshfeld surface analysis. Journal of Molecular Structure 1265, pages 133344.
Crossref
Crossref
Hao-Ran Zhang, Yu-Qing Song, Zhao-Qi Gong, Long-Yuan Zheng, Gui-Mei Tang & Yong-Tao Wang. (2022) Drug Ambroxol-based luminescent materials with sulfonate group: Synthesis, crystal structure and Hirshfeld surface analysis. Journal of Solid State Chemistry 314, pages 123387.
Crossref
Crossref
Simona Cavalu, Hossam Sharaf, Sameh Saber, Mahmoud E. Youssef, Amir Mohamed Abdelhamid, Ahmed A. E. Mourad, Samar Ibrahim, Shady Allam, Rehab Mohamed Elgharabawy, Eman El‐Ahwany, Noha A. Amin, Ahmed Shata, Mai Eldegla, Marina Atef, Maii Aboraya, Mayar Mohamed, Niera Anz, Dina Abd Elmotelb, Fayrouz Gabr, Dalia Elzablawy, Menna Hamada, Amr Yehia, Dalia Osama & Osama A. Mohammed. (2022)
Ambroxol, a mucolytic agent, boosts
HO
‐1, suppresses
NF‐κB
, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
. The FASEB Journal 36:9.
Crossref
Crossref
Seok-Man Park, Cheol-Jong Jung, Dae-Geon Lee, Beom-Rak Choi, Tae-Hun Ku, Im-Joung La, Il-Je Cho & Sae-Kwang Ku. (2022) Adenophora Stricta Root Extract Protects Lung Injury from Exposure to Particulate Matter 2.5 in Mice. Antioxidants 11:7, pages 1376.
Crossref
Crossref
Samantha Hughes, Maritza van Dop, Nikki Kolsters, David van de Klashorst, Anastasia Pogosova & Anouk M. Rijs. (2022) Using a Caenorhabditis elegans Parkinson’s Disease Model to Assess Disease Progression and Therapy Efficiency. Pharmaceuticals 15:5, pages 512.
Crossref
Crossref
Antje Neubert & Christopher Schulze. (2022) Selbstmedikation bei Kindern unter dem Aspekt der ArzneimitteltherapiesicherheitSelf-medication in children under the aspect of medication safety. Monatsschrift Kinderheilkunde 170:3, pages 237-246.
Crossref
Crossref
E. E. Lokshina & O. V. Zaytseva. (2022) Peculiarities of mucoactive therapy in pediatric practice. Meditsinskiy sovet = Medical Council:1, pages 97-104.
Crossref
Crossref
Lore Herman, Stefaan C. De Smedt & Koen Raemdonck. (2022) Pulmonary surfactant as a versatile biomaterial to fight COVID-19. Journal of Controlled Release 342, pages 170-188.
Crossref
Crossref
Maja Tomić & Uroš Pecikoza. (2022) Medications and non-pharmacological measures to alleviate the symptoms of respiratory tract infections in the pediatric population. Arhiv za farmaciju 72:3, pages 300-319.
Crossref
Crossref
Norikazu Kiguchi & Mei-Chuan Ko. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status
335
371
.
Christa E. Müller & Vigneshwaran Namasivayam. (2021) Recommended tool compounds and drugs for blocking P2X and P2Y receptors. Purinergic Signalling 17:4, pages 633-648.
Crossref
Crossref
Índia Olinta de Azevedo Queiroz, Thiago Machado, Camila Carneiro Alves, Victor Gustavo Balera Brito, Bruno Carvalho de Vasconcelos, João Eduardo Gomes-Filho, Edilson Ervolino, Sandra Helena Penha de Oliveira & Marco Antonio Hungaro Duarte. (2021) Biological and antimicrobial properties of the association Ambroxol and a water-soluble viscous liquid as a vehicle for a tricalcium silicate-based sealer. Journal of Materials Science: Materials in Medicine 32:12.
Crossref
Crossref
Rui Wang, Yali Sun, Wenxiu He, Yiting Chen, Enhao Lu & Xianyi Sha. (2021) Pulmonary surfactants affinity Pluronic-hybridized liposomes enhance the treatment of drug-resistant lung cancer. International Journal of Pharmaceutics 607, pages 120973.
Crossref
Crossref
Shengguang Wang, Zhen Li, Xinyu Wang, Shiming Zhang, Peng Gao & Zuorong Shi. (2021) The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19. Frontiers in Pharmacology 12.
Crossref
Crossref
Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Bradley J. Turner, Alexandre Henriques, Shyuan T. Ngo & Jean-Philippe Loeffler. (2021) Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Seminars in Cell & Developmental Biology 112, pages 82-91.
Crossref
Crossref
Emily C. Daykin, Emory Ryan & Ellen Sidransky. (2021) Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes. Molecular Genetics and Metabolism 132:2, pages 49-58.
Crossref
Crossref
Yuanfeng Zhang, Zheyi Wang, Yue Zhang, Hongxuan Tong, Yiling Zhang & Tao Lu. (2020) Potential Mechanisms for Traditional Chinese Medicine in Treating Airway Mucus Hypersecretion Associated With Coronavirus Disease 2019. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Giovanni Bocci, Steven B. Bradfute, Chunyan Ye, Matthew J. Garcia, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Shruti Bansal, Cristian G. Bologa, Douglas J. Perkins, Colleen B. Jonsson, Larry A. Sklar & Tudor I. Oprea. (2020)
Virtual and
In Vitro
Antiviral Screening Revive Therapeutic Drugs for COVID-19
. ACS Pharmacology & Translational Science 3:6, pages 1278-1292.
Crossref
Crossref
Matthew Alsaloum, Grant P. Higerd, Philip R. Effraim & Stephen G. Waxman. (2020) Status of peripheral sodium channel blockers for non-addictive pain treatment. Nature Reviews Neurology 16:12, pages 689-705.
Crossref
Crossref
Anna Furgała-Wojas, Magdalena Kowalska, Alicja Nowaczyk, Łukasz Fijałkowski & Kinga Sałat. (2020) Comparison of Bromhexine and its Active Metabolite - Ambroxol as Potential Analgesics Reducing Oxaliplatin-induced Neuropathic Pain - Pharmacodynamic and Molecular Docking Studies. Current Drug Metabolism 21:7, pages 548-561.
Crossref
Crossref
Alexandra Bouscary, Cyril Quessada, Frédérique René, Michael Spedding, Alexandre Henriques, Shyuan Ngo & Jean-Philippe Loeffler. (2020) Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases. European Journal of Pharmacology 884, pages 173446.
Crossref
Crossref
Pradeep Kumar. (2020) Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka & Maria Xilouri. (2020) In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Shikandar D. Bukkitgar, Nagaraj P. Shetti, Kakarla Raghava Reddy, Tawfik A. Saleh & Tejraj M. Aminabhavi. (2020) Ultrasonication and electrochemically-assisted synthesis of reduced graphene oxide nanosheets for electrochemical sensor applications. FlatChem 23, pages 100183.
Crossref
Crossref
Celine Ollier, Ulrike Sent, Margarida Mesquita & Martin C. Michel. (2020) Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers. Pulmonary Therapy 6:1, pages 119-130.
Crossref
Crossref
Alexandra Bouscary & Cyril Quessada. (2020) Potentiel thérapeutique de l’ambroxol contre les maladies du motoneurone. médecine/sciences 36:5, pages 447-448.
Crossref
Crossref
Wenjun Jiang, Mengni Yi, Gustavo H. B. Maegawa & Huiwen Zhang. (2019) Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease. Journal of Human Genetics 65:3, pages 345-349.
Crossref
Crossref
Akanksha Mishra & Sairam Krishnamurthy. (2019) Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson’s disease. Naunyn-Schmiedeberg's Archives of Pharmacology 393:3, pages 429-444.
Crossref
Crossref
Junwu Wang, Wensu Yu, Na Wu, ElaineN Gitonga & Haitao Shen. (2020) Efficacy of high-dose ambroxol for paraquat poisoning: A meta-analysis of randomized controlled trials. Journal of Research in Medical Sciences 25:1, pages 67.
Crossref
Crossref
A. Zanasi, M. Mazzolini & U. Caliceti. 2020. Cough: Pathophysiology, Diagnosis and Treatment. Cough: Pathophysiology, Diagnosis and Treatment
157
173
.
Olha Sviatenko, Nicolás Ríos‐Lombardía, Francisco Morís, Javier González‐Sabín, Kollipara Venkata Manideep, Simon Merdivan, Sebastian Günther, Philipp Süss & Matthias Höhne. (2019) One‐pot Synthesis of 4‐Aminocyclohexanol Isomers by Combining a Keto Reductase and an Amine Transaminase. ChemCatChem 11:23, pages 5794-5799.
Crossref
Crossref
C. R. A. Silveira, J. MacKinley, K. Coleman, Z. Li, E. Finger, R. Bartha, S. A. Morrow, J. Wells, M. Borrie, R. G. Tirona, C. A. Rupar, G. Zou, R. A. Hegele, D. Mahuran, P. MacDonald, M. E. Jenkins, M. Jog & S. H. Pasternak. (2019) Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurology 19:1.
Crossref
Crossref
Rita Sousa, Deepak R. Lakha, Sandrine Brette & Simon Hitier. (2019) A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ambroxol Hard-Boiled Lozenges in Patients with Acute Pharyngitis. Pulmonary Therapy 5:2, pages 201-211.
Crossref
Crossref
Pedro Modesto Nascimento Menezes, Mariana Coelho Brito, Pedro Guilherme Sousa de Sá, Luciano Augusto de Araújo Ribeiro, Larissa Araújo Rolim & Fabrício Souza Silva. (2019) Analytical and pharmacological validation of the quantification of phenol red in a mouse model: An optimized method to evaluate expectorant drugs. Journal of Pharmacological and Toxicological Methods 98, pages 106586.
Crossref
Crossref
Jin-Ryul Hu, Chul-Jong Jung, Seong-Min Ku, Dae-Hwa Jung, Sae-Kwang Ku & Jae-Suk Choi. (2019) Antitussive, expectorant, and anti-inflammatory effects of Adenophorae Radix powder in ICR mice. Journal of Ethnopharmacology 239, pages 111915.
Crossref
Crossref
Shruthi Sunkari, Sowjanya Thatikonda, Venkatesh Pooladanda, Veerabhadra Swamy Challa & Chandraiah Godugu. (2019) Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms. International Immunopharmacology 71, pages 301-312.
Crossref
Crossref
Kai‐Uwe Kern, Myriam Schwickert‐Nieswandt, Christian Maihöfner & Charly Gaul. (2019) Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia – A New Option? Initial Clinical Case Observations. Headache: The Journal of Head and Face Pain 59:3, pages 418-429.
Crossref
Crossref
Arturo Cortes-Telles, José Luis Che-Morales & Diana Lizbeth Ortiz-Farías. (2019) Estrategias actuales en el manejo de las secreciones traqueobronquiales. NCT Neumología y Cirugía de Tórax 78:3, pages 313-323.
Crossref
Crossref
Francesco Scaglione & Orlando Petrini. (2019) Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clinical Medicine Insights: Ear, Nose and Throat 12, pages 117955061882193.
Crossref
Crossref
Harsha P. Uskaikar, Nagaraj P. Shetti, Shikandar D. Bukkitgar, Shweta J. Malode, Nikita V. Jamakandi & T.M. Manu. (2019) Applications of zinc oxide nanoparticles as an electrode modifier for ambroxol. Materials Today: Proceedings 18, pages 963-967.
Crossref
Crossref
Peter Kardos, Kai-Michael Beeh, Ulrike Sent, Tobias Mueck, Heidemarie Gräter & Martin C. Michel. (2018) Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations. BMC Pharmacology and Toxicology 19:1.
Crossref
Crossref
Christian Maihöfner, Sabine Schneider, Patric Bialas, Helmut Gockel, Katrin-Grit Beer, Max Bartels & Kai-Uwe Kern. (2018) Successful treatment of complex regional pain syndrome with topical ambroxol: a case series. Pain Management 8:6, pages 427-436.
Crossref
Crossref
Anna Furgała, Łukasz Fijałkowski, Alicja Nowaczyk, Robert Sałat & Kinga Sałat. (2018) Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice. Biomedicine & Pharmacotherapy 106, pages 930-940.
Crossref
Crossref
Akanksha Mishra, Lalit Pratap Chandravanshi, Surendra Kumar Trigun & Sairam Krishnamurthy. (2018) Ambroxol modulates 6-Hydroxydopamine-induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson’s disease symptoms. Biochemical Pharmacology 155, pages 479-493.
Crossref
Crossref
Walaa H. Mahmoud, Gehad G. Mohamed, Hoda A. Elsawy & Mostafa A. Radwan. (2018) Metal complexes of novel Schiff base derived from the condensation of 2-quinoline carboxaldehyde and ambroxol drug with some transition metal ions. Applied Organometallic Chemistry 32:7, pages e4392.
Crossref
Crossref
Andrew T. Reid, Punnam Chander Veerati, Reinoud Gosens, Nathan W. Bartlett, Peter A. Wark, Chris L. Grainge, Stephen M. Stick, Anthony Kicic, Fatemeh Moheimani, Philip M. Hansbro & Darryl A. Knight. (2018) Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches. Pharmacology & Therapeutics 185, pages 155-169.
Crossref
Crossref
Thomas Haller, Alejandro Cerrada, Kristian Pfaller, Peter Braubach & Edward Felder. (2018) Polarized light microscopy reveals physiological and drug-induced changes in surfactant membrane assembly in alveolar type II pneumocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1860:5, pages 1152-1161.
Crossref
Crossref
J.D. Hull & R.A. Lyon. (2018) In vitro pharmacology of ambroxol: Potential serotonergic sites of action. Life Sciences 197, pages 67-72.
Crossref
Crossref
L. Kalyani & Chava V.N. Rao. (2018) Simultaneous spectrophotometric estimation of Salbutamol, Theophylline and Ambroxol three component tablet formulation using simultaneous equation methods. Karbala International Journal of Modern Science 4:1, pages 171-179.
Crossref
Crossref
J. Magalhaes, M. E. Gegg, A. Migdalska-Richards & A. H. Schapira. (2018) Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons. Scientific Reports 8:1.
Crossref
Crossref
David M. Pereira, Patrícia Valentão & Paula B. Andrade. (2018) Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones. Chemical Science 9:7, pages 1740-1752.
Crossref
Crossref
Xiuyun Li, Yuanhao Zhao, Xin Huang, Cuixiang Yu, Yilei Yang & Shujuan Sun. (2017) Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Ling-tian Ge, Ya-nan Liu, Xi-xi Lin, Hui-juan Shen, Yong-liang Jia, Xin-wei Dong, Yun Sun & Qiang-min Xie. (2016) Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway. International Immunopharmacology 33, pages 90-98.
Crossref
Crossref
Xinyang Su, Zefu Li, Meilin Wang, Zhenzhu Li, Qingbo Wang, Wenxian Lu, Xiaoli Li, Youfei Zhou & Hongmei Xu. (2016) The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A). Gene 577:1, pages 89-95.
Crossref
Crossref
Katsuyuki TakedaNobuaki MiyaharaShigeki MatsubaraChristian TaubeKenichi KitamuraAstushi HiranoMitsune TanimotoErwin W. Gelfand. (2016) Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Network 16:3, pages 165.
Crossref
Crossref
Giorgio Fois, Nina Hobi, Edward Felder, Andreas Ziegler, Pika Miklavc, Paul Walther, Peter Radermacher, Thomas Haller & Paul Dietl. (2015) A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca2+ release from acidic Ca2+ stores. Cell Calcium 58:6, pages 628-637.
Crossref
Crossref
Arun K. Baranwal, Aparna S. Murthy & Sunit C. Singhi. (2015) High-dose Oral Ambroxol for Early Treatment of Pulmonary Acute Respiratory Distress Syndrome: an Exploratory, Randomized, Controlled Pilot Trial. Journal of Tropical Pediatrics 61:5, pages 339-350.
Crossref
Crossref
F Guo, YB Sun, L Su, S Li, ZF Liu, J Li, XT Hu & J Li. (2014) Losartan attenuates paraquat-induced pulmonary fibrosis in rats. Human & Experimental Toxicology 34:5, pages 497-505.
Crossref
Crossref
Paulina Kubowicz, Henryk Marona & Elżbieta Pękala. (2015)
Synthesis, Anticonvulsant Activity and Metabolism of 4-chlor-3-methylphenoxyethylamine Derivatives of
Trans
-2-aminocyclohexan-1-ol
. Chirality 27:2, pages 163-169.
Crossref
Crossref
I. L. Klyachkina. (2015) The new possibility for the treatment of acute cough. Vestnik otorinolaringologii 80:5, pages 85.
Crossref
Crossref
Ola Ahmed Saleh, Ali Mohamed Yehia, Aida Abd-El Sattar El-Azzouny & Hassan Youssef Aboul-Enein. (2015) A validated chromatographic method for simultaneous determination of guaifenesin enantiomers and ambroxol HCl in pharmaceutical formulation. RSC Advances 5:114, pages 93749-93756.
Crossref
Crossref
Abdulkadir Levent, Yavuz Yardım & Zühre Şentürk. (2014) Electrochemical performance of boron-doped diamond electrode in surfactant-containing media for ambroxol determination. Sensors and Actuators B: Chemical 203, pages 517-526.
Crossref
Crossref
Yulia B. Monakhova, Matthias Kohl-Himmelseher, Thomas Kuballa & Dirk W. Lachenmeier. (2014) Determination of the purity of pharmaceutical reference materials by 1 H NMR using the standardless PULCON methodology. Journal of Pharmaceutical and Biomedical Analysis 100, pages 381-386.
Crossref
Crossref
Xiangdong Wu, Suwei Li, Jiuzhi Zhang, Yongli Zhang, Lili Han, Qiuming Deng & Xianyao Wan. (2014) Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials. The Journal of Clinical Pharmacology 54:11, pages 1199-1206.
Crossref
Crossref
Irina Vyacheslavovna Brzheskaya, Vladimir Vsevolodovich Brjesky & Mukhammed Radukhan. (2014) Current trends in the therapy of the ocular surface epithelial xerosis. Ophthalmology Reports 7:3, pages 45-56.
Crossref
Crossref
Muhammad Sharif, Anahit Pews-Davtyan, Jan Lukas, Susann Pohlers, Arndt Rolfs, Peter Langer & Matthias Beller. (2014) Palladium-catalysed Suzuki–Miyaura coupling reactions of Bromhexine and Ambroxol. Tetrahedron 70:34, pages 5128-5135.
Crossref
Crossref
M. Cataldi, V. Sblendorio, A. Leo & O. Piazza. (2014) Biofilm-dependent airway infections: A role for ambroxol?. Pulmonary Pharmacology & Therapeutics 28:2, pages 98-108.
Crossref
Crossref
TING ZHANG & XIANGDONG ZHOU. (2014) Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review). Experimental and Therapeutic Medicine 7:4, pages 763-767.
Crossref
Crossref
Jin Huang, Jianying Xu, Lin Tian & Liangwei Zhong. (2014) A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol. Biochimie 97, pages 92-103.
Crossref
Crossref
Vacis Tatarunas, Vaiva Lesauskaite, Audrone Veikutiene, Pranas Grybauskas, Povilas Jakuska, Laima Jankauskiene, Ruta Bartuseviciute & Rimantas Benetis. (2013) The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery. Journal of Thrombosis and Thrombolysis 37:2, pages 177-185.
Crossref
Crossref
Dongwook Kim, Hae Jin Kim, Joon Young Hyon, Won Ryang Wee & Young Joo Shin. (2013) Effects of Oral Mucolytics on Tear Film and Ocular Surface. Cornea 32:7, pages 933-938.
Crossref
Crossref
R. Scott Obach. (2013) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy. Pharmacological Reviews 65:2, pages 578-640.
Crossref
Crossref
Ari Zimran, Gheona Altarescu & Deborah Elstein. (2013) Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease. Blood Cells, Molecules, and Diseases 50:2, pages 134-137.
Crossref
Crossref
立明 张. (2013) Advantage of Prevention and Treatment in Neonatal Respiratory Distress Syndrome. Asian Case Reports in Pediatrics 01:01, pages 10-15.
Crossref
Crossref
Liangjie Tang, Stephen J. Coales, Jeffrey A. Morrow, Tim Edmunds & Yoshitomo Hamuro. (2012) Characterization of the N370S Mutant of Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry. ChemBioChem 13:15, pages 2243-2250.
Crossref
Crossref
Chunling Dong, Guifang Wang, Bo Li, Kui Xiao, Zhongsen Ma, Hua Huang, Xiangdong Wang & Chunxue Bai. (2012) Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma. Respiratory Physiology & Neurobiology 181:1, pages 21-28.
Crossref
Crossref
Sigrun Chrubasik, Beate Beime & Florella Magora. (2011) Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat. European Archives of Oto-Rhino-Laryngology 269:2, pages 571-577.
Crossref
Crossref
JeanClare Seagrave, Helmut H Albrecht, David B Hill, Duncan F Rogers & Gail Solomon. (2012) Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Respiratory Research 13:1, pages 98.
Crossref
Crossref
Meera Shanmuganathan & Philip Britz-McKibbin. (2011) Inhibitor screening of pharmacological chaperones for lysosomal β-glucocerebrosidase by capillary electrophoresis. Analytical and Bioanalytical Chemistry 399:8, pages 2843-2853.
Crossref
Crossref
Qiao-Ming Zhi, Li-tao Yang & Hai-chen Sun. (2011) Protective Effect of Ambroxol against Paraquat-induced Pulmonary Fibrosis in Rats. Internal Medicine 50:18, pages 1879-1887.
Crossref
Crossref
R. Balsamo, L. Lanata & C. G. Egan. (2010) Mucoactive drugs. European Respiratory Review 19:116, pages 127-133.
Crossref
Crossref
Andreas Leffler, Jennifer Reckzeh & Carla Nau. (2010) Block of sensory neuronal Na+ channels by the secreolytic ambroxol is associated with an interaction with local anesthetic binding sites. European Journal of Pharmacology 630:1-3, pages 19-28.
Crossref
Crossref
Ulrich Thaler, Paul Kraincuk, Lars-Peter Kamolz, Manfred Frey & Philipp G. H. Metnitz. (2010) Das Inhalationstrauma – Epidemiologie, Diagnostik und TherapieInhalation injury – Epidemiology, diagnosis and therapy. Wiener klinische Wochenschrift 122:1-2, pages 11-21.
Crossref
Crossref
B.F. Gibbs. (2009) Differential Modulation of IgE-Dependent Activation of Human Basophils by Ambroxol and Related Secretolytic Analogues. International Journal of Immunopathology and Pharmacology 22:4, pages 919-927.
Crossref
Crossref
Gustavo H.B. Maegawa, Michael B. Tropak, Justin D. Buttner, Brigitte A. Rigat, Maria Fuller, Deepangi Pandit, Liangiie Tang, Gregory J. Kornhaber, Yoshitomo Hamuro, Joe T.R. Clarke & Don J. Mahuran. (2009) Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease. Journal of Biological Chemistry 284:35, pages 23502-23516.
Crossref
Crossref
Bachir Latli, Matt Hrapchak, Heinz-Karl Switek, Daniel M. Retz, Dhileepkumar Krishnamurthy & Chris H. Senanayake. (2009) Synthesis of labeled ambroxol and its major metabolites. Journal of Labelled Compounds and Radiopharmaceuticals, pages n/a-n/a.
Crossref
Crossref